<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>24</volume><submitter>Wilson S</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>The effects of socio-economic status on mortality in patients with multiple sclerosis is not well known. The objective was to examine mortality due to multiple sclerosis according to socio-economic status.&lt;h4>Methods&lt;/h4>A retrospective observational cohort design was used with recruitment from 18 French multiple sclerosis expert centers participating in the &lt;i>Observatoire Français de la Sclérose en Plaques.&lt;/i> All patients lived in metropolitan France and had a definite or probable diagnosis of multiple sclerosis according to either Poser or McDonald criteria with an onset of disease between 1960 and 2015. Initial phenotype was either relapsing-onset or primary progressive onset. Vital status was updated on January 1st 2016. Socio-economic status was measured by an ec</pubmed_abstract><journal>The Lancet regional health. Europe</journal><pagination>100542</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9678948</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Effects of socioeconomic status on excess mortality in patients with multiple sclerosis in France: A retrospective observational cohort study.</pubmed_title><pmcid>PMC9678948</pmcid><pubmed_authors>Le Page E</pubmed_authors><pubmed_authors>Wilson S</pubmed_authors><pubmed_authors>Labauge P</pubmed_authors><pubmed_authors>Heinzlef O</pubmed_authors><pubmed_authors>Debouverie M</pubmed_authors><pubmed_authors>Rollot F</pubmed_authors><pubmed_authors>Moreau T</pubmed_authors><pubmed_authors>De Seze J</pubmed_authors><pubmed_authors>Remontet L</pubmed_authors><pubmed_authors>Vukusic S</pubmed_authors><pubmed_authors>Zephir H</pubmed_authors><pubmed_authors>Ciron J</pubmed_authors><pubmed_authors>Fauvernier M</pubmed_authors><pubmed_authors>Thouvenot E</pubmed_authors><pubmed_authors>Lebrun-Frenay C</pubmed_authors><pubmed_authors>Dejardin O</pubmed_authors><pubmed_authors>Berger E</pubmed_authors><pubmed_authors>Leray E</pubmed_authors><pubmed_authors>Pelletier J</pubmed_authors><pubmed_authors>Camdessanche JP</pubmed_authors><pubmed_authors>Clavelou P</pubmed_authors><pubmed_authors>Defer G</pubmed_authors><pubmed_authors>Tron L</pubmed_authors><pubmed_authors>Laplaud DA</pubmed_authors><pubmed_authors>Calocer F</pubmed_authors><pubmed_authors>Ruet A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Effects of socioeconomic status on excess mortality in patients with multiple sclerosis in France: A retrospective observational cohort study.</name><description>&lt;h4>Background&lt;/h4>The effects of socio-economic status on mortality in patients with multiple sclerosis is not well known. The objective was to examine mortality due to multiple sclerosis according to socio-economic status.&lt;h4>Methods&lt;/h4>A retrospective observational cohort design was used with recruitment from 18 French multiple sclerosis expert centers participating in the &lt;i>Observatoire Français de la Sclérose en Plaques.&lt;/i> All patients lived in metropolitan France and had a definite or probable diagnosis of multiple sclerosis according to either Poser or McDonald criteria with an onset of disease between 1960 and 2015. Initial phenotype was either relapsing-onset or primary progressive onset. Vital status was updated on January 1st 2016. Socio-economic status was measured by an ec</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jan</publication><modification>2026-05-27T19:11:07.405Z</modification><creation>2025-02-19T03:23:27.707Z</creation></dates><accession>S-EPMC9678948</accession><cross_references><pubmed>36426377</pubmed><doi>10.1016/j.lanepe.2022.100542</doi></cross_references></HashMap>